{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:50:26Z","timestamp":1760028626890},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":392,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jacc.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T01:21:13Z","timestamp":1487899273000},"page":"978-980","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The \u03b2 1 -Adrenergic Receptor IgG Subclass 3 Autoantibody in Dilated\u00a0Cardiomyopathy"],"prefix":"10.1016","volume":"69","author":[{"given":"Jignesh K.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.01.008_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.RES.64.1.97","article-title":"Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy","volume":"64","author":"Limas","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.01.008_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","article-title":"Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy","volume":"113","author":"Jahns","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.01.008_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCULATIONAHA.106.683193","article-title":"Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis","volume":"116","author":"Jane-wit","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.008_bib4","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1253\/circj.CJ-09-0748","article-title":"Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure","volume":"74","author":"Baba","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2017.01.008_bib5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jacc.2016.11.067","article-title":"Myocardial recovery in patients with systolic heart failure and autoantibodies against \u03b21 adrenergic receptors","volume":"69","author":"Nagatomo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.01.008_bib6","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jacc.2017.01.008_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0002-9440(10)64201-0","article-title":"Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes","volume":"161","author":"Zwaka","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacc.2017.01.008_bib8","doi-asserted-by":"crossref","first-page":"e002484","DOI":"10.1161\/JAHA.115.002484","article-title":"Full expression of cardiomyopathy is partly dependent on B-cells: a pathway that involves cytokine activation, immunoglobulin deposition, and activation of apoptosis","volume":"5","author":"Cordero-Reyes","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2017.01.008_bib9","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.CIR.0000036746.49449.64","article-title":"Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy","volume":"106","author":"Staudt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.01.008_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2016.03.005","article-title":"Autoantibodies specifically against beta1 adrenergic receptors and adverse clinical outcome in patients with chronic systolic heart failure in the beta-blocker era: the importance of immunoglobulin G3 subclass","volume":"22","author":"Nagatomo","year":"2016","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2017.01.008_bib11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00395-013-0384-7","article-title":"Anti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: comparison between carvedilol and metoprolol","volume":"108","author":"Le","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2017.01.008_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cardfail.2014.12.005","article-title":"Presence of autoantibody directed against beta1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2017.01.008_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.autrev.2010.05.013","article-title":"Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application","volume":"9","author":"Tzioufas","year":"2010","journal-title":"Autoimmun Rev"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717301225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717301225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:57:32Z","timestamp":1536015452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717301225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0735109717301225"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.01.008","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b21-Adrenergic Receptor IgG Subclass 3 Autoantibody in Dilated\u00a0Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.11.067","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}